Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the second quarter of 2022.
In this edition, fail-safe classes fail, consumers smoke a motion to dismiss, and you can’t bring it if you don’t know whodunit. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the second quarter.
Please see full publication below for more information.
